Pharmacy

The updated COVID-19 boosters aimed at targeting omicron subvariants BA.4 and BA.5 could soon be authorized for people 12 and older, White House COVID-19 response coordinator Ashish Jha, MD, told NBC News Aug. 17.

The Inflation Reduction Act of 2022 opens the door for Medicare to negotiate prices for certain drugs — a change that drug manufacturers strongly oppose. 

As Walgreens is offering bonuses up to $75,000 to recruit pharmacists and workforce shortages are hindering pharmacy services, such as prescribing COVID-19 antiviral drugs, some local pharmacies may soon see more customers. 

Medly Pharmacy has let go of 16 percent of its workforce, the digital pharmacy's chief executive wrote in a recent LinkedIn post.

Global drugmaker Sanofi is dropping its treatment intended for breast cancer after a phase 3 trial with other drugs failed to meet progression-free survival goals. 

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

Vaccine-maker Moderna appointed James Mock to become the Cambridge, Mass-based company's CFO starting Sept. 6. 

A subsidiary of pharmaceutical company Johnson & Johnson, LTL Management, said in court documents that bankruptcy is the only option to settle the thousands of lawsuits lodged against J&J's talc-based baby powder, The Wall Street Journal reported Aug. 16. 

In a volley between the FDA and Emergent BioSolutions over the biotech's Baltimore facility, the agency said Emergent was "inadequate" in its efforts to fix drug manufacturing errors. 

Novavax, a pharmaceutical company that recently gained the FDA's emergency use authorization for its COVID-19 vaccine, is now pushing for its booster candidate to be authorized for adults.